Aminoglycoside research 1975-1985: prospects for development of improved agents.
作者信息
Price K E
出版信息
Antimicrob Agents Chemother. 1986 Apr;29(4):543-8. doi: 10.1128/AAC.29.4.543.
Abstract
摘要
相似文献
1
Aminoglycoside research 1975-1985: prospects for development of improved agents.
Antimicrob Agents Chemother. 1986 Apr;29(4):543-8. doi: 10.1128/AAC.29.4.543.
2
A survey of extended-interval aminoglycoside dosing practices in United States adult cystic fibrosis programs.
Respir Care. 2014 Sep;59(9):1353-9. doi: 10.4187/respcare.02980. Epub 2014 Apr 29.
3
[The pharmacokinetic interpretation of the nephrotoxic effect of aminoglycosides and the influence of cephalosporins on the aminoglycoside nephrotoxic effect].
Antibiot Khimioter. 1989 Dec;34(12):920-5.
4
Aminoglycoside therapy. Current use and future prospects.
Pharm Weekbl Sci. 1990 Jun 22;12(3):81-90. doi: 10.1007/BF01967600.
5
Plazomicin: A Novel Aminoglycoside for the Treatment of Resistant Gram-Negative Bacterial Infections.
Drugs. 2019 Feb;79(3):243-269. doi: 10.1007/s40265-019-1054-3.
6
Reappraisal of Contemporary Pharmacokinetic and Pharmacodynamic Principles for Informing Aminoglycoside Dosing.
Pharmacotherapy. 2018 Dec;38(12):1229-1238. doi: 10.1002/phar.2193.
7
[Value of aminoglycoside antibiotics in the therapy of bacterial infections].
Med Klin (Munich). 1993 Jul 15;88(7):438-44.
8
[Aminoglycoside single or multiple daily doses?].
Ugeskr Laeger. 1993 Dec 20;155(51):4192-4.
9
[Molecular mechanisms underlying renal accumulation of aminoglycoside antibiotics and mechanism-based approach for developing nonnephrotoxic aminoglycoside therapy].
Yakugaku Zasshi. 2006 May;126(5):327-35. doi: 10.1248/yakushi.126.327.
10
Aminoglycoside-induced ototoxicity.
Curr Pharm Des. 2007;13(1):119-26. doi: 10.2174/138161207779313731.
引用本文的文献
1
Once-daily aminoglycoside dosing: A new look at an old drug.
Can J Infect Dis. 1994 Sep;5(5):205-6. doi: 10.1155/1994/796138.
2
Mechanisms of aminoglycoside ototoxicity and targets of hair cell protection.
Int J Otolaryngol. 2011;2011:937861. doi: 10.1155/2011/937861. Epub 2011 Oct 25.
3
Aminoglycosides: nephrotoxicity.
Antimicrob Agents Chemother. 1999 May;43(5):1003-12. doi: 10.1128/AAC.43.5.1003.
4
Aminoglycosides: activity and resistance.
Antimicrob Agents Chemother. 1999 Apr;43(4):727-37. doi: 10.1128/AAC.43.4.727.
5
Bacterial resistance after in vitro exposure to amikacin and netilmicin.
Eur J Clin Microbiol. 1986 Aug;5(4):456-8. doi: 10.1007/BF02075708.
6
Enhanced gentamicin killing of Escherichia coli by tet gene expression.
Antimicrob Agents Chemother. 1989 Feb;33(2):230-2. doi: 10.1128/AAC.33.2.230.
7
In vitro activity of dactimicin, a novel pseudodisaccharide aminoglycoside, compared with activities of other aminoglycosides.
Antimicrob Agents Chemother. 1989 Nov;33(11):1998-2003. doi: 10.1128/AAC.33.11.1998.
8
Once-daily aminoglycoside administration: new strategies for an old drug.
Eur J Clin Microbiol Infect Dis. 1989 Sep;8(9):761-9. doi: 10.1007/BF02185842.
9
Dactimicin, a new aminoglycoside: in vitro activity, post-antibiotic effect and interaction with other antibiotics.
Eur J Clin Microbiol Infect Dis. 1989 Jul;8(7):639-43. doi: 10.1007/BF01968148.
10
Discovery and development of new antimicrobial agents.
Clin Microbiol Rev. 1990 Jan;3(1):13-31. doi: 10.1128/CMR.3.1.13.
本文引用的文献
1
GENTAMICIN, A NEW ANTIBIOTIC COMPLEX FROM MICROMONOSPORA.
J Med Chem. 1963 Jul;6:463-4. doi: 10.1021/jm00340a034.
2
Production and isolation of a new antibiotic: kanamycin.
J Antibiot (Tokyo). 1957 Sep;10(5):181-8.
3
Compound A49759, the 3-O-demethyl derivative of fortimicin A: in vitro comparison with six other aminoglycoside antibiotics.
Antimicrob Agents Chemother. 1980 Nov;18(5):773-9. doi: 10.1128/AAC.18.5.773.
4
Comparative antimicrobial activity of O-demethylfortimicin A, a derivative of fortimicin A.
Antimicrob Agents Chemother. 1980 Nov;18(5):766-72. doi: 10.1128/AAC.18.5.766.
5
Comparative nephrotoxicities of high-dose netilmicin and tobramycin in rats.
Antimicrob Agents Chemother. 1980 Aug;18(2):346-8. doi: 10.1128/AAC.18.2.346.
6
Comparative low-dose nephrotoxicities of gentamicin, tobramycin, and amikacin.
Antimicrob Agents Chemother. 1980 Jul;18(1):176-81. doi: 10.1128/AAC.18.1.176.
7
Acute and subacute toxicity studies with fortimicin A sulfate (Abbott-44747), a new aminoglycoside antibiotic.
Toxicol Appl Pharmacol. 1980 May;53(3):399-409. doi: 10.1016/0041-008x(80)90353-1.
8
Nonparallel nephrotoxicity dose-response curves of aminoglycosides.
Antimicrob Agents Chemother. 1981 Jun;19(6):1024-8. doi: 10.1128/AAC.19.6.1024.
9
Prospective comparative study of efficacy and toxicity of netilmicin and amikacin.
Antimicrob Agents Chemother. 1980 Feb;17(2):217-25. doi: 10.1128/AAC.17.2.217.
10
Long-term amikacin use. Effects on aminoglycoside susceptibility patterns of gram-negative bacilli.
JAMA. 1982 Sep 10;248(10):1199-202. doi: 10.1001/jama.248.10.1199.
Zotero 插件